Dow Down1.10% Nasdaq Down1.82%

Endocyte, Inc. (ECYT)

-NasdaqGS
2.82 Down 0.20(6.62%) 4:00PM EST
|After Hours : 2.82 Up 0.00 (0.02%) 4:59PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 33   13   13   13  
Cost of Revenue -   -   -   -  
Gross Profit 33   13   13   13  
Operating Expenses
Research Development6,581  6,724  6,617  3,997  
Selling General and Administrative3,777  4,071  4,360  4,201  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (10,326) (10,782) (10,965) (8,186)
Income from Continuing Operations
Total Other Income/Expenses Net324  178  95  106  
Earnings Before Interest And Taxes(10,002)(10,604)(10,870)(8,079)
Interest Expense -   -   -  1  
Income Before Tax(10,002)(10,604)(10,870)(8,081)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(10,002)(10,604)(10,870)(8,081)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,002) (10,604) (10,870) (8,081)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,002) (10,604) (10,870) (8,081)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.